Retrobulbar Sinus Injection of Doxorubicin is More Efficient Than Lateral Tail Vein Injection at Inducing Experimental Nephrotic Syndrome in Mice: A Pilot Study
Open Access
- 24 January 2019
- journal article
- research article
- Published by SAGE Publications in Laboratory Animals
- Vol. 53 (6) , 564-576
Abstract
Doxorubicin-induced nephropathy in mice is a model for studying experimental nephrotic syndrome. It corresponds to puromycin aminonucleoside nephrosis in rats. In this model, susceptible 129 S1/SvImJ mice are administered a rapid intravenous injection that can be accomplished via either the lateral tail vein or the retrobulbar sinus. Because doxorubicin is a highly toxic substance, extravasation must be avoided during the administration of the intravenous injection to prevent the development of large necrotizing lesions and exacerbation of the animals’ stress. In the present study, we compared the safety and stress of these two injection routes by using histopathological analyses of the animals’ orbital cavities or tails, respectively. The injection of 14.5 µg/g body weight doxorubicin into the mice’s lateral tail veins ( n = 9) or retrobulbar sinuses ( n = 19) caused no clinically detectable stress or impairment. Histopathologies of the specimens five days after doxorubicin injection revealed inflammatory lesions at the injection sites in both groups. In the orbital sinus specimens from the retrobulbar-injected group, fibrosis was evident 25 days after injection. Moreover, while all of the retrobulbar-injected mice (100%) developed nephrotic syndrome, tail vein-injected mice had a significantly lower response rate (66%, p = 0.047, Fisher’s exact test) and exhibited only attenuated features of nephrotic syndrome. It was therefore concluded that doxorubicin administration via either lateral tail vein or retrobulbar sinus injections led to a similar induction of histopathological changes with no effects on the clinical well-being of the mice. However, retrobulbar sinus injections were more efficient for inducing experimental nephrotic syndrome.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (AR 1092/2-1)
This publication has 34 references indexed in Scilit:
- Retro-orbital injections in miceLab Animal, 2011
- Adriamycin nephropathy: A model of focal segmental glomerulosclerosisNephrology, 2010
- Over-expression of adenosine deaminase in mouse podocytes does not reverse puromycin aminonucleoside resistanceBMC Nephrology, 2010
- Coding of facial expressions of pain in the laboratory mouseNature Methods, 2010
- Podocin Inactivation in Mature Kidneys Causes Focal Segmental Glomerulosclerosis and Nephrotic SyndromeJournal of the American Society of Nephrology, 2009
- Serum- and glucocorticoid-inducible kinase 1 in doxorubicin-induced nephrotic syndromeAmerican Journal of Physiology-Renal Physiology, 2008
- Comparison of the lateral tail vein and the retro-orbital venous sinus as routes of intravenous drug delivery in a transgenic mouse modelLab Animal, 2008
- Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearanceAmerican Journal of Physiology-Renal Physiology, 2004
- The course of the remnant kidney model in miceKidney International, 1999
- IL-1-like production in adriamycin-induced nephrotic syndrome in the ratClinical and Experimental Immunology, 1992